Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Johnson

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Archives of General Psychiatry|October 4, 2006
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effectsMatthew W Johnson, Patricia E Suess, Roland R Griffiths
Addictive Behaviors|September 27, 2014
Cocaine dependent individuals discount future rewards more than future losses for both cocaine and monetary outcomesMatthew W Johnson, Natalie R Bruner, Patrick S Johnson
Journal of the Experimental Analysis of Behavior|November 13, 2014
Opportunity costs of reward delays and the discounting of hypothetical money and cigarettesPatrick S Johnson, Evan S Herrmann, Matthew W Johnson
Archives of Sexual Behavior|April 21, 2023
Delay Discounting and Sexual Decision-Making: Understanding Condom Use Behavior Among U.S. College StudentsLuke D Mitzel, Matthew W Johnson, Peter A Vanable
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 17, 2023
E-cigarette Price Impacts legal and Black-Market Cigarette Purchasing Under a Hypothetical Reduced-Nicotine Cigarette StandardSean B Dolan, Melissa K Bradley, Matthew W Johnson
Journal of the Experimental Analysis of Behavior|August 20, 2024
R<sup>2</sup> should not be used to describe behavioral-economic discounting and demand modelsBrett W Gelino, Justin C Strickland, Matthew W Johnson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 10, 2015
Psychedelic medicine: a re-emerging therapeutic paradigmKenneth W Tupper, Evan Wood, Richard Yensen, et al.
Journal of Psychopharmacology (Oxford, England)|October 20, 2021
A narrative synthesis of research with 5-MeO-DMTAnna O Ermakova, Fiona Dunbar, James Rucker, et al.
Journal of Psychopharmacology (Oxford, England)|July 12, 2017
Who is 'Molly'? MDMA adulterants by product name and the impact of harm-reduction services at ravesSarah Saleemi, Steven J Pennybaker, Missi Wooldridge, et al.
Experimental and Clinical Psychopharmacology|April 21, 2020
A systematic review and meta-analysis of delay discounting and cannabis useJustin C Strickland, Dustin C Lee, Ryan Vandrey, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Archives of General Psychiatry|October 4, 2006
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effectsMatthew W Johnson, Patricia E Suess, Roland R Griffiths
Addictive Behaviors|September 27, 2014
Cocaine dependent individuals discount future rewards more than future losses for both cocaine and monetary outcomesMatthew W Johnson, Natalie R Bruner, Patrick S Johnson
Journal of the Experimental Analysis of Behavior|November 13, 2014
Opportunity costs of reward delays and the discounting of hypothetical money and cigarettesPatrick S Johnson, Evan S Herrmann, Matthew W Johnson
Archives of Sexual Behavior|April 21, 2023
Delay Discounting and Sexual Decision-Making: Understanding Condom Use Behavior Among U.S. College StudentsLuke D Mitzel, Matthew W Johnson, Peter A Vanable
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 17, 2023
E-cigarette Price Impacts legal and Black-Market Cigarette Purchasing Under a Hypothetical Reduced-Nicotine Cigarette StandardSean B Dolan, Melissa K Bradley, Matthew W Johnson
Journal of the Experimental Analysis of Behavior|August 20, 2024
R<sup>2</sup> should not be used to describe behavioral-economic discounting and demand modelsBrett W Gelino, Justin C Strickland, Matthew W Johnson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 10, 2015
Psychedelic medicine: a re-emerging therapeutic paradigmKenneth W Tupper, Evan Wood, Richard Yensen, et al.
Journal of Psychopharmacology (Oxford, England)|October 20, 2021
A narrative synthesis of research with 5-MeO-DMTAnna O Ermakova, Fiona Dunbar, James Rucker, et al.
Journal of Psychopharmacology (Oxford, England)|July 12, 2017
Who is 'Molly'? MDMA adulterants by product name and the impact of harm-reduction services at ravesSarah Saleemi, Steven J Pennybaker, Missi Wooldridge, et al.
Experimental and Clinical Psychopharmacology|April 21, 2020
A systematic review and meta-analysis of delay discounting and cannabis useJustin C Strickland, Dustin C Lee, Ryan Vandrey, et al.
Pageof 18